EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | C37H66NO18R |
| Net Charge | 0 |
| Average Mass (excl. R groups) | 812.917 |
| Monoisotopic Mass (excl. R groups) | 812.42799 |
| SMILES | *C(=O)N[C@@H](CO[C@@H]1O[C@H](CO)[C@@H](O[C@@H]2O[C@H](CO)[C@H](O[C@H]3O[C@H](CO)[C@H](O)[C@H](O)[C@H]3O)[C@H](O)[C@H]2O)[C@H](O)[C@H]1O)[C@H](O)/C=C/CCCCCCCCCCCCC |
| Species of Metabolite | Component | Source | Comments |
|---|---|---|---|
| Mus musculus (ncbitaxon:10090) | - | PubMed (19425150) | Source: BioModels - MODEL1507180067 |
| Roles Classification |
|---|
| Biological Roles: | antigen Any substance that stimulates an immune response in the body, such as through antibody production or by presentation to a T-cell receptor after binding to a major histocompability complex (MHC). mouse metabolite Any mammalian metabolite produced during a metabolic reaction in a mouse (Mus musculus). |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| α-D-galactosyl-(1→4)-β-D-galactosyl-(1→4)-β-D-glucosylceramide (CHEBI:18313) has role antigen (CHEBI:59132) |
| α-D-galactosyl-(1→4)-β-D-galactosyl-(1→4)-β-D-glucosylceramide (CHEBI:18313) has role mouse metabolite (CHEBI:75771) |
| α-D-galactosyl-(1→4)-β-D-galactosyl-(1→4)-β-D-glucosylceramide (CHEBI:18313) is a glycotriaosylceramide (CHEBI:36508) |
| α-D-galactosyl-(1→4)-β-D-galactosyl-(1→4)-β-D-glucosylceramide (CHEBI:18313) is a α-D-galactosyl-(1→4)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1)-ceramide (CHEBI:88154) |
| Incoming Relation(s) |
| α-D-Gal-(1→3)-α-D-Gal-(1→4)-β-D-Gal-(1→4)-β-D-Glc-(1↔1')-N- acylsphingosine (CHEBI:140745) has functional parent α-D-galactosyl-(1→4)-β-D-galactosyl-(1→4)-β-D-glucosylceramide (CHEBI:18313) |
| α-D-galactosyl-D-galactosyl-D-glucosylsphingosine (CHEBI:228802) has functional parent α-D-galactosyl-(1→4)-β-D-galactosyl-(1→4)-β-D-glucosylceramide (CHEBI:18313) |
| β-D-GlcNAc-(1→3)-α-D-Gal-(1→4)-β-D-Gal-(1→4)-β-D-Glc-(1↔1')-ceramide(d18:1(4E)) (CHEBI:141182) has functional parent α-D-galactosyl-(1→4)-β-D-galactosyl-(1→4)-β-D-glucosylceramide (CHEBI:18313) |
| α-D-Gal-(1→4)-β-D-Gal-(1→4)-β-D-Glc-(1↔1')-Cer(d18:1/26:1(17Z)) (CHEBI:133816) is a α-D-galactosyl-(1→4)-β-D-galactosyl-(1→4)-β-D-glucosylceramide (CHEBI:18313) |
| α-D-galactosyl-(1→4)-β-D-galactosyl-(1→4)-β-D-glucosyl-N-hexacosanoylceramide (CHEBI:75188) is a α-D-galactosyl-(1→4)-β-D-galactosyl-(1→4)-β-D-glucosylceramide (CHEBI:18313) |
| IUPAC Name |
|---|
| N-[(2S,3R,4E)-1-{[α-D-galactopyranosyl-(1→4)-β-D-galactopyranosyl-(1→4)-β-D-glucopyranosyl]oxy}-3-hydroxyoctadec-4-en-2-yl]alkanamide |
| Synonyms | Source |
|---|---|
| Trihexosylceramide | KEGG COMPOUND |
| Gal-alpha1->4LacCer | KEGG COMPOUND |
| D-Galactosyl-1,4-D-galactosyl-1,4-D-glucosylceramide | KEGG COMPOUND |
| Globotriosylceramide | KEGG COMPOUND |
| Gal-α1→4LacCer | KEGG COMPOUND |
| α-D-galactosyl-(1→4)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1)-ceramide | ChEBI |
| UniProt Name | Source |
|---|---|
| a globoside Gb3Cer (d18:1(4E)) | UniProt |
| Manual Xrefs | Databases |
|---|---|
| C04737 | KEGG COMPOUND |
| G00093 | KEGG GLYCAN |
| D-GALACTOSYL-14-D-GALACTOSYL-14-D- | MetaCyc |
| Registry Numbers | Sources |
|---|---|
| CAS:71965-57-6 | ChemIDplus |
| CAS:71965-57-6 | KEGG COMPOUND |
| Citations |
|---|